title: Response of normal canine ureter to photodynamic therapy using a cylindrical fiber.
abstract: Photodynamic therapy (PDT) was performed utilizing a cylindrical optical fiber to determine feasibility of distal ureteral treatment on 10 study and two control NIH foxhounds. The study animals were administered three mg./kg. dihematoporphyrin ether (Photofrin II) intravenously followed 48 hours later by open cystotomy. One ureter was irradiated with 42 joules of 630 nm. light delivered by a 660 micron diameter optical fiber modified for cylindrical light distribution. Intravenous urography was performed both at three days and six weeks post PDT. Hydroureteronephrosis was revealed in one treated ureter and one untreated ureter. Mild dilatation of the ureter was noted by urography in another treated ureter and in one ureter that did not undergo light irradiation; no distal obstruction was revealed in either case by proximal infusion of saline or by histopathology. Nine of the 10 treated ureters were found to have either no abnormal pathology or only minimal lymphocytic infiltration. In this study, the normal ureter was shown to tolerate photodynamic therapy at energy densities equivalent to those used to effect tumor regression and the feasibility of using a cylindrical optical fiber for treatment of ureteral malignancies was confirmed.
authors.affiliation: Radiation Oncology, Branche National Institutes of Health, Bethesda, MD 20892.
authors.forename: M J
authors.initials: MJ
authors.lastname: Manyak
authors.forename: D M
authors.initials: DM
authors.lastname: Matthews
authors.forename: P D
authors.initials: PD
authors.lastname: Smith
authors.forename: L E
authors.initials: LE
authors.lastname: Nochomovitz
authors.forename: E
authors.initials: E
authors.lastname: Glatstein
authors.forename: A
authors.initials: A
authors.lastname: Russo
mesh_terms: D000818:Animals; D002295:Carcinoma, Transitional Cell / Q000628:therapy; D004285:Dogs; D005336:Fiber Optic Technology / Q000295:instrumentation*; D006801:Humans; D006869:Hydronephrosis / Q000000981:diagnostic imaging / Q000209:etiology; D008297:Male; D008954:Models, Biological; D055100:Optical Fibers; D010778:Photochemotherapy / Q000009:adverse effects* / Q000379:methods; D014513:Ureter / Q000000981:diagnostic imaging / Q000473:pathology*; D014515:Ureteral Diseases / Q000000981:diagnostic imaging / Q000209:etiology; D001749:Urinary Bladder Neoplasms / Q000628:therapy; D014567:Urography